Valuation: Jerusalem Pharmaceuticals Co. Ltd.

Market Cap 124M 111M 102M 92.71M 173M 11.79B 177M 1.22B 490M 6.2B 466M 456M 19.56B P/E 2024
13.7x
P/E 2025 8.13x
Enterprise Value 113M 101M 93.34M 84.57M 158M 10.76B 161M 1.11B 447M 5.66B 425M 416M 17.85B EV / Sales 2024
1.47x
EV / Sales 2025 1.47x
Free-Float
34.87%
Yield 2024
2.09%
Yield 2025 3.26%
1 day-1.15%
1 week+2.07%
1 month-2.27%
3 months-8.00%
6 months-9.45%
Current year+50.00%
1 week 3.33
Extreme 3.33
3.49
1 month 3.33
Extreme 3.33
3.6
Current year 2.28
Extreme 2.285
4
1 year 2.01
Extreme 2.01
4
3 years 1.74
Extreme 1.745
4
5 years 1.36
Extreme 1.355
4
10 years 0.8
Extreme 0.795
4
Manager TitleAgeSince
Chief Executive Officer - 30/06/2013
Director of Finance/CFO - 29/02/2020
Chief Tech/Sci/R&D Officer - 31/12/1988
Director TitleAgeSince
Chairman 91 -
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-1.15%+2.07%+72.50%+84.99% 124M
+3.19%+11.31%+64.28%+155.91% 1,263B
-0.73%+3.56%+44.65%+84.17% 658B
+1.41%+3.24%+35.25%+108.88% 521B
+0.42%+3.20%+55.81%+72.50% 391B
+2.18%+2.93%+73.90%+45.59% 369B
+1.12%+4.52%+34.76%+58.24% 307B
+6.96%+8.86%+11.95%+36.20% 290B
+1.15%+6.09%+56.15%+82.25% 252B
+3.06%+9.38%+42.48%+117.32% 212B
Average +1.76%+5.31%+49.17%+84.60% 426.21B
Weighted average by Cap. +2.01%+6.60%+50.51%+100.44%

Financials

2024 2025
Net sales 39.82M 35.66M 32.81M 29.72M 55.56M 3.78B 56.6M 391M 157M 1.99B 149M 146M 6.27B 48.95M 43.84M 40.32M 36.53M 68.29M 4.65B 69.57M 481M 193M 2.44B 184M 180M 7.71B
Net income 5.04M 4.51M 4.15M 3.76M 7.03M 478M 7.16M 49.49M 19.87M 252M 18.91M 18.5M 794M 10.18M 9.12M 8.39M 7.6M 14.21M 967M 14.47M 100M 40.16M 509M 38.22M 37.4M 1.6B
Net Debt -10.32M -9.24M -8.5M -7.7M -14.4M -980M -14.67M -101M -40.71M -516M -38.74M -37.91M -1.63B -10.9M -9.76M -8.98M -8.13M -15.2M -1.03B -15.49M -107M -42.97M -544M -40.89M -40.02M -1.72B
Projected Income Statement - Annual - Jerusalem Pharmaceuticals Co. Ltd.
Logo Jerusalem Pharmaceuticals Co. Ltd.
Jerusalem Pharmaceuticals Co Ltd (Al-Quds) is a Palestine-based public shareholding company engaged in the manufacture and trade of pharmaceutical, veterinary, detergent, and cosmetics products. Its product range spans the whole spectrum of ethical pharmaceuticals, as well as over the counter preparations and nutritional supplements. Its Products are presented in different dosage forms such as tablets, capsules, ampoules, granules and powders for suspensions, suspensions, syrups, lotions, powders, suppositories, ovules, creams, ointments, gels, emulgels, ear, eye and nose drops, solutions, mouth rinse and gargles. The Company also produces veterinary products including vials, powders, oral liquids and fodder additives such as multivitamins and multi-minerals. It also manufactures detergents and cosmetics under license from French companies. The Company operates three production facilities include Factory for General Production, Penicillin Factory and Cephalosporin Factory.
Employees
595
Date Price Change Volume
29/10/26 US$3.450 -1.15% 1,109
27/10/26 US$3.490 +2.65% 240
25/10/26 US$3.400 +0.59% 9,200